| __timestamp | Amicus Therapeutics, Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 20622000 |
| Thursday, January 1, 2015 | 47269000 | 33837000 |
| Friday, January 1, 2016 | 71151000 | 35979000 |
| Sunday, January 1, 2017 | 88671000 | 25003000 |
| Monday, January 1, 2018 | 127200000 | 19269000 |
| Tuesday, January 1, 2019 | 169861000 | 15426000 |
| Wednesday, January 1, 2020 | 156407000 | 14456000 |
| Friday, January 1, 2021 | 192710000 | 20488000 |
| Saturday, January 1, 2022 | 213041000 | 27195000 |
| Sunday, January 1, 2023 | 275270000 | 30914000 |
Cracking the code
In the competitive world of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Over the past decade, Amicus Therapeutics, Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting approaches in their SG&A expenditures. From 2014 to 2023, Amicus Therapeutics has seen a staggering increase of over 1,200% in their SG&A spending, reflecting their aggressive growth strategy and market expansion efforts. In contrast, Celldex Therapeutics has maintained a more conservative approach, with their SG&A expenses growing by approximately 50% over the same period. This divergence highlights the varied strategies companies employ to navigate the biotech landscape. As Amicus continues to invest heavily in its operations, Celldex's steady approach may suggest a focus on sustainable growth. These spending patterns offer a glimpse into the strategic priorities of these two industry players.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
Grifols, S.A. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
CymaBay Therapeutics, Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of MorphoSys AG and Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs MannKind Corporation
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends